WPP bid for Grey trumps the competition

Share this article:

Grey shareholders were being offered $1,005 per share under the deal. The agreement, which will allow Grey to operate under its own name, calls for 50 percent of Grey shares to be exchanged for cash and 50 percent of Grey shares to be exchanged for American Depository Shares of WPP.

Grey chairman and chief executive Ed Meyer reportedly will continue with the agency for two more years, according to a report in The New York Times.

In addition to its roster of blue-chip consumers clients, including Procter & Gamble, 3M, Mars and Warner Bros., Grey also operates the full-service medical agency Grey Healthcare Group.

Share this article:
close

Next Article in News

Email Newsletters

More in News

Five things for pharma marketers to know: Thursday, August 21

Five things for pharma marketers to know: Thursday, ...

An Ebola survivor is set to leave Emory University Hospital, but the cause of the cure is uncertain, the FDA has approved a new type 1 diabetes test, and the ...

Sanofi expands Gaucher disease portfolio

Sanofi expands Gaucher disease portfolio

The oral medication Cerdelga joins Cerezyme in its Gaucher disease arsenal. Sanofi expects the drug will be priced "on par" with Cerezyme, which goes for around $300,000 a year in ...

Amicus seeks to upset Fabry market

Amicus seeks to upset Fabry market

Phase-III tests indicate patients may be able to switch from injectable enzyme-replacement therapies, like Fabrazyme, to the firm's oral drug.